TelyRx Holdings (TELYF) Stock Price, News & Analysis
Price Move History
- Daily moves over 5%
- 27 52 sessions, June 11, 2026 to November 5, 2026
- Largest daily move
- -17.1% close of June 22, 2026
- 1-month change
- +7.1% closing prices, October 2, 2026 to November 5, 2026
Company Description
TelyRx Holdings (OTC: TELYF) is classified in the pharmaceutical retailers industry within the Healthcare sector.
TELYF has gained 7.1% over the past month. The last closing price was $1.89.
This page collects what Stock Titan holds for TELYF, including price data, latest news, upcoming events, and short interest trends.
Stock Performance
TelyRx Holdings (TELYF) closed at $1.89 on November 5, 2026. Over the past month, the price has gained 7.1%.
TELYF Metrics & Rankings
Price returns through November 5, 2026. Month and year figures include the first trading day. Ranking links may use different dates.
Latest News
TelyRx Holdings has 10 recent news articles, with the latest published today. Of the recent coverage, 6 articles coincided with positive price movement and 2 with negative movement. Key topics include earnings, conferences, earnings date. View all TELYF news →
SEC Filings
Financial Highlights
Upcoming Events
Q3 2026 Conference Call
TelyRx Holdings has 1 upcoming scheduled event. The next event, "Q3 2026 Conference Call", is scheduled for November 6, 2026 (tomorrow). It is an earnings release or call. Investors can track these dates to stay informed about potential catalysts that may affect the TELYF stock price.
Short Interest History
Short interest in TelyRx Holdings (TELYF) currently stands at 11.9 thousand shares, up 17.2% from the previous reporting period, representing 0.1% of the float. Since June 2026, short interest has increased by 3791.8%.
Days to Cover History
Days to cover for TelyRx Holdings (TELYF) currently stands at 42.2 days, up 1760.4% from the previous period. The ratio is the reported short interest divided by the average daily trading volume. Since June 2026, the figure has increased by 673.4%. Across the settlements charted above, it has ranged from 1.5 to 42.2 days.
TELYF Company Profile & Sector Positioning
TelyRx Holdings (TELYF) operates in the Pharmaceutical Retailers industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing TELYF often look at related companies in the same sector, including Bioscience Health Innov (BHIC), Scientist Home FTR Hlth (SHFH), Polomar Health Svcs Inc (PMHS), Blum Holdings Inc. (BLMH), and HealthWarehouse.com (HEWA). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate TELYF's relative position within its industry.